Overview

A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601

Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
This study is designed to provide ganaxolone to those patients deriving significant benefit from current treatment in protocol 1042-0601.
Phase:
Phase 2
Details
Lead Sponsor:
Marinus Pharmaceuticals
Treatments:
Ganaxolone
Pregnanolone